Medical Grade Chitosan Market

Chitosan (CS) is a linear polysaccharide which is achieved by deacetylation of chitin, which is the second most plentiful compound in nature, after cellulose. Chitosan was applied in pharmaceutics/drug/gene delivery and cell encapsulation. Chitosan was applied in binding to protein drugs, contact lenses and implants. GMP grade chitosan covers chitosan for a variety of medical applications.

Medical Grade Chitosan Market contains market size and forecasts of Medical Grade Chitosan in global, including the following market information:

Global Medical Grade Chitosan Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Medical Grade Chitosan Market Sales, 2017-2022, 2023-2028, (Ton)

Global top five Medical Grade Chitosan companies in 2021 (%)

The global Medical Grade Chitosan market was valued at 35 million in 2021 and is projected to reach US$ 58 million by 2028, at a CAGR of 7.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Animal Origin Chitosan Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Medical Grade Chitosan include Primex, KitoZyme, BIO21, YSK, Vietnam Food, NovaMatrix, KIMICA, Ningbo Zhenhai Haixin Biological and Golden-Shell Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Medical Grade Chitosan manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Medical Grade Chitosan Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Ton)

Global Medical Grade Chitosan Market Segment Percentages, by Type, 2021 (%)

Animal Origin Chitosan

Plant Based Chitosan

Global Medical Grade Chitosan Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Ton)

Global Medical Grade Chitosan Market Segment Percentages, by Application, 2021 (%)

Wound Care

Healthcare Products

Antibacterial Products

Others

Global Medical Grade Chitosan Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Ton)

Global Medical Grade Chitosan Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Medical Grade Chitosan revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Medical Grade Chitosan revenues share in global market, 2021 (%)

Key companies Medical Grade Chitosan sales in global market, 2017-2022 (Estimated), (Ton)

Key companies Medical Grade Chitosan sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Primex

KitoZyme

BIO21

YSK

Vietnam Food

NovaMatrix

KIMICA

Ningbo Zhenhai Haixin Biological

Golden-Shell Pharmaceutical

Zhejiang Fengrun Biotech

Jiangsu Shuanglin

Jiangsu Aoxin Biotechnology

Qingdao Yunzhou Biochemistry